Skip to main content

Increased Exposure to PFAS, Phenols Linked to Prior Cancer Diagnosis

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Sept. 25, 2023 -- Per- and polyfluoroalkyl substances (PFAS), phenols, and parabens are associated with a previous cancer diagnosis, according to a study published online Sept. 18 in the Journal of Exposure Science & Environmental Epidemiology.

Amber L. Cathey, Ph.D., from the University of Michigan in Ann Arbor, and colleagues used data from the National Health and Nutrition Examination Survey to assess cross-sectional associations between biomarkers of PFAS, phenols, and parabens and self-reported previous cancer diagnoses among men and women aged 20 years and older. Concentrations of seven PFAS and 12 phenols/parabens were extracted, and the associated odds ratios for self-reported previous diagnoses of melanoma and cancers of the thyroid, breast, ovary, uterus, and prostate were assessed.

The researchers found that in women, greater perfluorodecanoic acid (PFDE), perfluorononanoic acid (PFNA), and perfluoroundecanoic acid (PFUA) were associated with increased odds of previous melanoma (odds ratios [ORs], 2.07, 1.72, and 1.76, respectively). Among women, a previous melanoma diagnosis was also linked to elevated levels of benzophenone-3 (BP3), 2,5-dichlorophenol (DCP25), and 2,4-dichlorophenol (ORs, 1.81, 2.41, and 1.85, respectively). In addition, the odds of previous ovarian cancer were increased in association with elevated levels of DCP25, bisphenol-A, and BP3 (ORs, 2.80, 1.93, and 1.76, respectively). Odds of previous uterine cancer were increased in association with increased PFNA (OR, 1.55), while the highest versus lowest category of ethyl paraben resulted in lower odds of uterine cancer (OR, 0.31).

"These PFAS chemicals appear to disrupt hormone function in women, which is one potential mechanism that increases odds of hormone-related cancers in women," Cathey said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted September 2023

Read this next

Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual Adults

FRIDAY, July 19, 2024 -- With respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females...

Neighborhood Disadvantage Metrics Tied to Stress Genes in Prostate Cancer

FRIDAY, July 19, 2024 -- Expression of several stress-related genes in prostate tumors is elevated among men residing in disadvantaged neighborhoods, according to a study...

Some Women in Their 40s Prefer to Delay Breast Cancer Screening

MONDAY, July 15, 2024 -- A considerable proportion of women aged 39 to 49 years prefer to delay breast cancer screening, especially after a decision aid (DA) intervention...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.